Randomized, Double bind, Two arm, Multicentric, Comparative Controlled, Prospective Clinical trial of Mycobacterium w in combination with satandard therapy versus standard therapy alone in sepsis due to gram (-) ve infections.
Phase of Trial: Phase II
Latest Information Update: 26 Aug 2016
At a glance
- Drugs Cadi 05 (Primary) ; Aminoglycosides; Cephalosporins; Imipenem; Meropenem
- Indications Gram-negative infections; Sepsis; Septic shock
- Focus Therapeutic Use
- 15 Feb 2012 Status changed from recruiting to completed as reported by Clinical Trials Registry - India.
- 01 Jul 2009 New trial record